Internal Medicine, Hematology & Oncology · Irvine, CA
NPI
1477729861
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
6650 Alton Pkwy, Hematology and Oncology, Mob 2, 4th Floor
Irvine, CA, 92618
Phone (949) 932-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
1,847 services
Medicare patients, 2024
11
Average age 66
Drug cost, 2024
$7.1M
2,639 prescriptions
Company payments, 2025
$96.32
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug David Y Lou prescribed most often to Medicare patients was Abiraterone Acetate, with 858 prescriptions and refills. In total David Y Lou wrote 2,639 Medicare prescriptions that cost $7.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-30.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Abiraterone Acetate Generic | 858 | 904 | 107 | $103K |
| Prednisone Generic | 429 | 1,020 | 117 | $3,594 |
| Xtandi Enzalutamide | 168 | 168 | 24 | $1.8M |
| Potassium Chloride Generic | 107 | 197 | 43 | $1,862 |
| Dexamethasone Generic | 105 | 155 | 31 | $1,971 |
| Tagrisso Osimertinib Mesylate | 92 | 92 | 11 | $1.6M |
| Lenalidomide Generic | 92 | 92 | Under 11 | $948K |
| Anastrozole Generic | 90 | 280 | 30 | $2,546 |
| Ondansetron Hcl Generic | 63 | 63 | 26 | $540 |
| Bicalutamide Generic | 44 | 63 | 22 | $1,601 |
| Inlyta Axitinib | 32 | 32 | Under 11 | $360K |
| Eliquis Apixaban | 31 | 43 | Under 11 | $28K |
| Hydroxyurea Generic | 29 | 87 | Under 11 | $1,320 |
| Tabrecta Capmatinib Hydrochloride | 28 | 28 | Under 11 | $493K |
| Duloxetine Hcl Generic | 26 | 53 | Under 11 | $349 |
Brand drugs: 528 claims; generic drugs: 2,111 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David Y Lou $96.32 ($96.32 in general payments such as food, travel and fees) from 1 company. The largest payer was AstraZeneca Pharmaceuticals LP with $96.32.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $96.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.